MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of CAD 84.85 million. The enterprise value is 220.58 million.
Market Cap | 84.85M |
Enterprise Value | 220.58M |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +6.67% |
Shares Change (QoQ) | +0.29% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 342.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.87, with an EV/FCF ratio of -27.91.
EV / Earnings | -11.56 |
EV / Sales | 1.00 |
EV / EBITDA | 7.87 |
EV / EBIT | 20.78 |
EV / FCF | -27.91 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.03.
Current Ratio | 1.27 |
Quick Ratio | 0.40 |
Debt / Equity | 1.03 |
Debt / EBITDA | 4.47 |
Debt / FCF | -15.29 |
Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is -15.15% and return on invested capital (ROIC) is 2.79%.
Return on Equity (ROE) | -15.15% |
Return on Assets (ROA) | 2.35% |
Return on Capital (ROIC) | 2.79% |
Revenue Per Employee | 312,701 |
Profits Per Employee | -27,988 |
Employee Count | 721 |
Asset Turnover | 0.78 |
Inventory Turnover | 3.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.00% in the last 52 weeks. The beta is 2.80, so MariMed's price volatility has been higher than the market average.
Beta (5Y) | 2.80 |
52-Week Price Change | -55.00% |
50-Day Moving Average | 0.22 |
200-Day Moving Average | 0.29 |
Relative Strength Index (RSI) | 51.11 |
Average Volume (20 Days) | 25,884 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, MariMed had revenue of CAD 213.26 million and -19.09 million in losses. Loss per share was -0.05.
Revenue | 213.26M |
Gross Profit | 91.16M |
Operating Income | 10.24M |
Pretax Income | -13.98M |
Net Income | -19.09M |
EBITDA | 24.25M |
EBIT | 10.24M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 13.22 million in cash and 120.83 million in debt, giving a net cash position of -107.60 million.
Cash & Cash Equivalents | 13.22M |
Total Debt | 120.83M |
Net Cash | -107.60M |
Net Cash Per Share | n/a |
Equity (Book Value) | 117.32M |
Book Value Per Share | 0.25 |
Working Capital | 16.32M |
Cash Flow
In the last 12 months, operating cash flow was 14.09 million and capital expenditures -22.00 million, giving a free cash flow of -7.90 million.
Operating Cash Flow | 14.09M |
Capital Expenditures | -22.00M |
Free Cash Flow | -7.90M |
FCF Per Share | n/a |
Margins
Gross margin is 42.74%, with operating and profit margins of 4.80% and -8.95%.
Gross Margin | 42.74% |
Operating Margin | 4.80% |
Pretax Margin | -6.55% |
Profit Margin | -8.95% |
EBITDA Margin | 11.37% |
EBIT Margin | 4.80% |
FCF Margin | -3.71% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.67% |
Shareholder Yield | -6.67% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.71. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.71 |
Piotroski F-Score | n/a |